A participatory process to design an app to improve adherence to anti-osteoporotic therapies: A development and usability study

Digit Health. 2023 Dec 11:9:20552076231218858. doi: 10.1177/20552076231218858. eCollection 2023 Jan-Dec.

Abstract

Objective: The aim of the study was to develop an app to improve patients' adherence to therapy for osteoporosis and to test its usability.

Methods: In Phase I, the app functions needed to improve medication adherence were identified through a focus group with six patients with osteoporosis and a joint interview with two bone specialists. The app prototype was then developed (Phase II) and refined after its feasibility testing (Phase III) for 13-25 days by eight patients. Finally, the app underwent usability testing (Phase IV) for 6 months by nine other patients. The mHealth App Usability Questionnaire (MAUQ) was used to collect the assessment of the app by the 17 patients.

Results: The final version of the app provided information on osteoporosis, allowed patients to contact the bone specialist for an additional consultation, and generated a reminder for taking medications accompanied by feedback on adherence. The assessment of the app was positive but evaluations differed between the feasibility and usability testing, with the former displaying a significantly (p ≤ .05) better assessment across all MAUQ items.

Conclusions: In this study, we tested an app for improving adherence to medical therapies in patients with osteoporosis. The usability testing revealed a lower "patient-centered" performance of the app as compared to that observed during the feasibility phase. Future developments of the study include increasing the testing cohort and adding a technical support during the usability testing.

Keywords: App; adherence; anti-osteoporotic therapies; mHealth; participatory design.